Apellis Pharmaceuticals, Inc. (APLS)
23.76
-0.02
(-0.11%)
USD |
NASDAQ |
Dec 09, 13:56
Apellis Pharmaceuticals Market Cap: 3.007B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 26.11B |
| Amicus Therapeutics, Inc. | 3.038B |
| Fortress Biotech, Inc. | 90.01M |
| Ultragenyx Pharmaceutical, Inc. | 3.494B |
| Fulcrum Therapeutics, Inc. | 800.41M |
Market Cap Related Metrics
| PE Ratio | 80.02 |
| PS Ratio | 2.958 |
| Price to Book Value | 7.495 |
| Price to Free Cash Flow | 38.23 |
| Price | 23.76 |
| Earnings Yield | 1.25% |
| Operating PE Ratio | 37.39 |
| Normalized PE Ratio | 80.02 |